• Report Details: This report is based on analysis of financial balance sheet and income statement data for the period of 2000-2012, quantitative survey research results, and interactions with pharmaceutical clients in supply chain strategy engagements.
  • Objective: To use financial balance sheet and income statement data coupled with recent research to better understand the state of pharmaceutical supply chains.
  • Hypothesis: The pharmaceutical industry has struggled as a result of the Great Recession, complexities inherited as a result of M&A activity, and confronts looming Patent Cliffs requiring it to adapt and adopt new techniques to prioritize supply chain excellence and regain stability.


Full Report

View more documents from Lora Cecere, Abby Mayer and Supply Chain Insights